Comparison of de novo tumours after liver transplantation with incidence rates from Italian cancer registries

Digestive and Liver Disease

Volumn 42, Issue 1, 2010, Pages 55-60

  Baccarani, U ^a   Piselli, P ^b   Serraino, D ^c   Adani, G L ^a   Lorenzin, D ^a   Gambato, M ^d   Buda, A ^d   Zanus, G ^d   Vitale, A ^f   De Paoli, A ^c   Cimaglia, C ^b   Bresadola, V ^a   Toniutto, P ^a   Risaliti, A ^e   Cillo, U ^d   Bresadola, F ^a   Burra, P ^d  

^a UNIVERSITY HOSPITAL OF UDINE   (Italy)

^b NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^c CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^d UNIVERSITY OF PADOVA   (Italy)

^e UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^f VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

Author keywords

De novo tumour; Immunosuppression; Liver transplantation; Tumour after transplantation

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER REGISTRY; CANCER RISK; CANCER SURVIVAL; COMPARATIVE STUDY; CONTROLLED STUDY; ESOPHAGUS CARCINOMA; FEMALE; FOLLOW UP; GRAFT RECIPIENT; HEAD AND NECK CANCER; HUMAN; HUMAN TISSUE; ITALY; KAPOSI SARCOMA; LIVER TRANSPLANTATION; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MORBIDITY; NONHODGKIN LYMPHOMA; OUTCOME ASSESSMENT; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; STOMACH CANCER; SURVIVAL RATE; SURVIVAL TIME; TUMOR BIOPSY; TUMOR LOCALIZATION; UTERINE CERVIX CANCER;

FEMALE; HUMANS; INCIDENCE; ITALY; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; NEOPLASMS; POSTOPERATIVE COMPLICATIONS; REGISTRIES; RISK; SURVIVAL ANALYSIS;

EID: 73149116454     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2009.04.017     Document Type: Article

References (32)

1. National Institutes of Health. National Institutes of Health Consensus Development Conference Statement: liver transplantation, June 20-23, 1983. Hepatology 4 (1984) 107
2. Haagsma E.B., Hagens V.E., Schaapveld M., van den Berg A.P., de Vries E.G., Klompmaker I.J., et al. Increased cancer risk after liver transplantation: a population-based study. J Hepatol 34 (2001) 84
3. Buell J.F., Gross T.G., and Woodle E.S. Malignancy after transplantation. Transplantation 80 (2005) S254
4. Penn I. Occurrence of cancers in immunosuppressed organ transplant recipients. In: Cecka J.M., and Terasaki P.I. (Eds). Clinical transplant 1998 (1998), UCLA Tissue Typing Laboratory, Los Angeles 147
5. Buell J., Hanaway M., and Thomas M. Malignancies associated with liver transplantation. In: Busuttil R.W., and Klintmalm G.B. (Eds). Transplantation of the liver (2004), W.B. Saunders, Philadelphia
6. Fung J.J., Jain A., Kwak E.J., Kusne S., Dvorchik I., and Eghtesad B. De novo malignancies after liver transplantation: a major cause of late death. Liver Transpl 7 (2001) S109
7. Serraino D., Piselli P., Busnach G., Burra P., Citterio F., Arbustini E., et al. Risk of cancer following immunosuppression in organ transplant recipients and in HIV-positive individuals in southern Europe. Eur J Cancer 43 (2007) 2117
8. Cancer Incidence in Five Continents, Volumes I to IX. International Agency for Resaerch on Cancer (IARC). http://www-dep.iarc.fr/.
9. Breslow N.E., and Day N.E. Statistical methods in cancer research Vol. 2. The design and analysis of cohort studies (1987), IARC Press, Lyon [IARC Scientific Publications No. 82]
10. Saigal S., Norris S., Muiesan P., Rela M., Heaton N., and O'Grady J. Evidence of differential risk for posttransplantation malignancy based on pretransplantation cause in patients undergoing liver transplantation. Liver Transpl 8 (2002) 482
11. Haagsma E.B., Hagens V.E., and Schaapveld M. Increased cancer risk after liver transplantation: a population-based study. J Hepatol 34 (2001) 84
12. Oo Y.H., Gunson B.K., Lancashire R.J., Cheng K.K., and Neuberger J.M. Incidence of cancers following orthotopic liver transplantation in a single center: comparison with national cancer incidence rates for England and Wales. Transplantation 80 (2005) 759
13. Sanchez E.Q., Marubashi S., Jung G., Levy M.F., Goldstein R.M., Molmenti E.P., et al. De novo tumors after liver transplantation: a single-institution experience. Liver Transpl 8 (2002) 285
14. Jain A.B., Yee L.D., Nalesnik M.A., Youk A., Marsh G., Reyes J., et al. Comparative incidence of de novo nonlymphoid malignancies after liver transplantation under tacrolimus using surveillance epidemiologic end result data. Transplantation 66 (1998) 1193
15. Frezza E.E., Fung J.J., and van Thiel D.H. Non-lymphoid cancer after liver transplantation. Hepatogastroenterology 44 (1997) 1172
16. Xiol X., Guardiola J., Menendez S., Lama C., Figueras J., Marcoval J., et al. Risk factors for development of de novo neoplasia after liver transplantation. Liver Transpl 7 (2001) 971
17. Benlloch S., Berenguer M., Prieto M., Moreno R., San Juan F., Rayón M., et al. De novo internal neoplasms after liver transplantation: increased risk and aggressive behavior in recent years?. Am J Transpl 4 (2004) 596
18. Watson R.R. Ethanol, immunomodulation and cancer. Prog Food Nutr Sci 12 (1988) 189
19. Roselle G., Mendenhall C.L., and Grossman C.J. Effects of alcohol on immunity and cancer. In: Yirmiya R., and Taylor A.N. (Eds). Alcohol, immunity, and cancer (1993), CRC, Boca Raton, FL 3
20. Ben-Eliyahu S., Page G.G., Yirmiya R., and Taylor A.N. Acute alcohol intoxication suppresses natural killer cell activity and promotes tumor metastasis. Nat Med 2 (1996) 457
21. Lotzova E. Definition and functions of natural killer cells. Nat Immun 12 (1993) 169
22. Mather G.G., Talcott P.A., and Exon J.H. Characterisation of a chemically induced tumor model and the effects of natural killer cell depletion by antisialo GM-1. Immunobiology 190 (1994) 333
23. Penn I. Cancer in the immunosuppressed organ recipient. Transpl Proc 23 (1991) 1771
24. Adami J., Gäbel H., Lindelöf B., Ekström K., Rydh B., Glimelius B., et al. Cancer risk following organ transplantation: a nationwide cohort study in Sweden. Br J Cancer 89 (2003) 1221
25. Presser S.J., Schumacher G., Neuhaus R., Thuss-Patience P., Stieler J., and Neuhaus P. De novo esophageal neoplasia after liver transplantation. Liver Transpl 13 (2007) 443
26. Yu M.C., Garabrant D.H., Peters J.M., and Mack T.M. Tobacco, alcohol, diet, occupation, and carcinoma of the esophagus. Cancer Res 48 (1988) 3843
27. Kusne S., and Blair J.E. Viral and fungal infections after liver transplantation-part II. Liver Transpl 12 (2006) 2
28. Dukers N.H.T.M., and Rezza G. Human Herpesvirus 8 epidemiology: what we do and do not know. AIDS 17 (2003) 1717
29. Viswanatha D.S., and Dogan A. Hepatitis C virus and lymphoma. J Clin Pathol 60 (2007) 1378
30. Buda A., Caforio A., Calabrese F., Fagiuoli S., Pevere S., Livi U., et al. Lymphoproliferative disorders in heart transplant recipients: role of hepatitis C virus (HCV) and Epstein-Barr virus (EBV) infection. Transpl Int 13 (2000) S402
31. Morton L.M., Landgren O., Chatterjee N., Castenson D., Parsons R., Hoover R.N., et al. Hepatitis C virus infection and risk of posttransplantation lymphoproliferative disorder among solid organ transplant recipients. Blood 110 (2007) 4599
32. McLaughlin K., Wajstaub S., Marotta P., Adams P., Grant D.R., Wall W.J., et al. Increased risk for posttransplant lymphoproliferative disease in recipients of liver transplants with hepatitis C. Liver Transpl 6 (2000) 570